Products for Research Use Only
RegisterLogin

Parsatuzumab

CAT: 0804-HY-P99215-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99215-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Parsatuzumab (Anti-EGFL7; RG 7414) is a humanized monoclonal antibody, acts as an immunomodulator and binds to EGFL7. Parsatuzumab selectively blocks the interaction between EGFL7 and endothelial cells, potentially inhibiting vascular regrowth and reducing vascular endothelial growth factor (VEGF) inhibition[1].
CAS Number
1312797-14-0
Product Name Alternative
Anti-EGFL7; RG 7414
UNSPSC
12352203
Target
VEGFR
Type
Inhibitory Antibodies
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/parsatuzumab.html
Purity
97.94
Solubility
10 mM in DMSO
Smiles
[Parsatuzumab]
Molecular Weight
(148.22 kDa)
References & Citations
[1]García-Carbonero R, et al. Randomized Phase II Trial of Parsatuzumab (Anti-EGFL7) or Placebo in Combination with FOLFOX and Bevacizumab for First-Line Metastatic Colorectal Cancer. Oncologist. 2017 Apr;22 (4) :375-e30. |[2]Chinmayee Goda, et al. Dorrance, Epidermal Growth Factor-like 7 As a Novel Therapeutic Target in Mantle Cell Lymphoma. Blood. 138 (S1), 2021:3300.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1

Alternative Products

CatalogName
M36701-01Parsatuzumab
GTR18338030-01Parsatuzumab Antibody
CBA1068-01Parsatuzumab Biosimilar
C00310-1mgParsatuzumab (Anti-EGFL7)
MBS1563970-01Research Grade Parsatuzumab
KBI1544KRIBIOLISA™ Parsatuzumab ELISA
592098-01EGFL7, Parsatuzumab Biosimilar
047751EGFL7 (parsatuzumab) discontinued
E55B0596Parsatuzumab (Reference antibody)
F2083-5Anti-EGFL7 Antibody (Parsatuzumab)

Popular Products